Hosted on MSN2h
Advocates respond to stricter reporting guidelines for drug, DV cases in Jackson CountyJackson County is making changes in how domestic violence and drug distribution cases are handled. Certain incidents are ...
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
Amid outbreaks of bird flu in the U.S., experts weigh in on best practices for preparing eggs safely. See the video from ...
16h
Medpage Today on MSNDr. Oz's Healthcare Stocks; Drug Tariffs Coming? Why Doctors Like 'The Pitt'Celebrity doctor Mehmet Oz, MD, Trump's pick to head CMS, pledged to divest millions from drug, medical, and insurance ...
The proposed 'Say No to Drugs' sign is just one of several measures aimed at making concerts safer for everyone. Local ...
WASHINGTON — Processed food companies and federal nutrition guidelines and programs could be in the crosshairs of President Donald Trump’s new Make America Healthy Again (MAHA) Commission, according ...
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...
Those with wealth and influence are not just tolerating Nigeria’s booming illegal drug trade, they are fueling it.
Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.
SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results